Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Ceren Türkcan Kayhan (Izmir, Turkey), Ceren Turkcan Kayhan, Raziye Hilal Senay, Esra Feyzioglu, Fulden Zeynep Ural, Ozlem Goksel, Tuncay Goksel, Suleyman Gulcemal, Munevver Erdinc, Sinan Akgol. Development of a novel nano-sized carrier system for aeroseol drug delivery (EGE University translational pulmonology research group). Eur Respir J 2015; 46: Suppl. 59, 2134

Member's Comments

No comment yet.

Related content which might interest you: DEAE-dextran MMA copolymer non-viral vector for aerosol therapy in respiratory diseases Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013 Research in respiratory medicine - strategies for success: preparation materials Source: ERS Course 2015 Year: 2015 Mesoporous silica-based nanoparticles for targeted delivery of proteasome inhibitors to the lung Source: Annual Congress 2013 –Cutting edge: drug delivery to the airways Year: 2013 Late Breaking Abstract - Implementation of universal valid methodology in the diagnosis of occupational asthma(Ege University Translational Pulmonology Research Group [EgeTPAG]) Source: International Congress 2017 – Case reports and series Year: 2017 Redefining the asthma treatment paradigm using a locally administered dual PI3Kgd inhibitor Source: International Congress 2016 – New therapies and therapeutic targets Year: 2016 Prospects for new compounds tiosemikarbazonami class to create drugs with antituberculosis activity Source: International Congress 2014 – Tuberculosis: diagnosis Year: 2014 Research in respiratory medicine: New approaches in genetic diseases Source: ERS Summit on priorities in respiratory medicine 2011 Year: 2011 Development of a lung slice methodology to study the mechanisms of lung uptake and lysosomal trapping Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Medical aerosols delivery hospitals and home, what is new? Source: Annual Congress 2007 - Primary care: delivering the goods: "inhaled therapies" Year: 2007 Simulation of particle deposition in the human airways Source: Annual Congress 2013 –Airway calibre, airway challenge and assessment of oxygenation Year: 2013 Digital Therapy in the treatment of asthma and COPD - Epidemiology of development and use of an emerging health technology in Respiratory Medicine Source: International Congress 2019 – M-health/e-health II Year: 2019 New interactive 3D visualization technique used in pulmonary rehabilitation programme in COPD, a randomized controlled study Source: International Congress 2016 – Latest insights into pulmonary rehabilitation Year: 2016 Workshop 1: Lung Clearance Index – demonstration of devices utilised by the core facility; best practices and different approaches to communication with pharmaceutical companies Source: International Congress 2016 – PD5 Establishing core facilities for measuring clinical trial outcomes  Year: 2016 The European Respiratory Review: continuing the success and targeting new challenges Source: Eur Respir Rev, 28 (151) 190001; 10.1183/16000617.0001-2019 Year: 2019 Human translational medicine in ILD: the promise of new drugs Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 Confirmation of preclinical data on tioureidoiminomethylpyridinium perchlorate in treatment of MDR-TB Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015 Effectiveness of Simulation based training in patient safety - Validation study for Georges patient safety in simulation tool Source: International Congress 2014 – Medical education: web and internet Year: 2014 In vitro pharmacological characterization of two novel dual-acting MABA compounds (LAS190792 and LAS191351) Source: International Congress 2014 – Novel targets and drugs for asthma and COPD Year: 2014 New and future developments of therapy for asthma in children Source: Eur Respir Mon 2012; 56: 224-234 Year: 2012 Clinical use of new and repurposed drugs: the role and contribution of the ERS collaborative projects Source: International Congress 2017 – In the frontline of the fight against tuberculosis Year: 2017